|
Tuesday 25th July
Plenary 3: Controversies and consensus in maternal - child health
(sponsored by Mead Johnson)
Chairs: Robert Gibson and Susan Carlson
Plenary 3.1 Bioactive lipids and their nutrient interactions
Sheila Innis, Canada
Plenary 3.2 Prenatal fatty acid exposure and early immune development
Susan Prescott, Australia
Plenary 3.3 Systematic reviews and large scale randomised controlled trials: we’ve come a long way baby!
Maria Makrides, Australia
Chairs: Michel Narce & Robert Pawlosky
CS 9.1 DHA accumulation in ALA fed rats is regulated by the pufa and fat content of the diet.
Gibson R.
CS 9.2 Dietary α-linolenate (ALA) reduces the impact of essential fatty acid (EFA) deficiency on fatty acid profiles in the rat: could low ω-3 fatty acid intake actually decrease the requirement for linoleate (LA)?
Cunnane S.
CS 9.3 Docosahexaenoic acid addition to the diet results in a decrease in the net accretion of long chain polyunsaturated fatty acids.
Salem N. Jr.
CS 9.4 Does retroconversion contribute to the limited accumulation of DHA from precursor fatty acids?
Portolesi R.
CS 9.5 High monounsaturated fat diets regulate the synthesis of docosahexaenoic acid.
Murphy K.
CS 9.6 Compartmental analyses of plasma 13C- and 2H-labeled n-6 fatty acids arising from oral administrations of 13C-U-18:2 n-6 and 2H5-20:3 n-6 in newborn infants.
Pawlosky R.
Chairs:Carol Lammi-Keefe & Marcello Giovannini
CS 10.1 Influence of fatty acid intake during pregnancy on cytokine levels in cord blood.
Enke U.
CS 10.2 Docosahexaenoic acid concentration in rat plasma and liver is affected by sex and pregnancy.
Childs C.
CS 10.3 Aquatic foods, and fatty acid intake and status of pregnant women and neonates from three regions of China. Zhang J.
CS 10.4 Mouse fetal brain long chain polyunsaturated fatty acids (LCP) are strongly related to LCP in maternal erythrocytes (RBC) and brain.
Van Goor S.
CS 10.5 Stimulation of fatty acid uptake in human placental choriocarcinoma (BeWo) cells by polyunsaturated fatty acids. Duttaroy A.
CS 10.6 Relative quantification of fatty acid transport protein-1 (FATP-1), FATP-4 and heart-fatty acid binding protein (H-FABP) gene expression in human term placenta.
Koletzko B.
Chairs: Anne Minihane & Robert Metcalf
CS 11.1 Health effects of monounsaturated fatty acids (MUFA) and selected bioactive compounds in food sources of MUFA.
Kris-Etherton P.
CS 11.2 Fish, fish oils and long chain omega-3 fatty acids – cardiac benefit and risk: review by the Nutrition and Metabolism Committee of the National Heart Foundation of Australia.
Colquhoun D.
CS 11.3 Effect of olive oils on the hepatic proteome and atherosclerosis development in apolipoprotein E knockout mice. De Roos B.
CS 11.4 Meal fatty acids influence postprandial vascular reactivity.
Jackson K.
CS 11.5 Running on fish oil: benefits of omega-3 supplementation and exercise.
Hill A.
Chairs: Tamas Decsi & Laszlo Puskas
CS 12.1 Exceptionally fast rates of docosahexaenoic acid chain isomerization - a NMR study.
Gawrisch K.
CS 12.2 Innovative multidimensional gas chromatography systems applied to the analysis of complex fats and oils. Mondello L.
CS 12.3 Determination of cholesterol ester and triacylglycerol profiles in human plasma by using comprehensive two-dimensional HLPC-APCI-MS.
Dugo P.
CS 12.4 Method for adjusting percentage of fatty acids in red blood cells to control for peroxidation during storage. Magnusardottir A.
CS 12.5 Different bioavailability of n-3 pufa after consumption of n-3 fa containing foods or formulations, assessed in blood drops from a fingertip in healthy subjects.
Galli C.
CS 12.6 A comparison of a rapid finger prick blood sample/direct microwave methylation method with conventional methods for the determination of omega-3 fatty acids.
Stark K.
Chairs: Norman Salem Jr & Michi Sugano
CS 13.1 Counteracting effects of statins and cigarette smoke on polyunsaturated fatty acid metabolism.
Rise P.
CS 13.2 Dietary stearidonic acid (18:4ω-3) metabolises to omega 3 long chain polyunsaturated fatty acids in farmed Atlantic salmon.
Miller M.
CS 13.3 Fatty acid desaturase MMA expression in blood samples from healthy volunteers correlates with plasma phospholipid pufa status.
Thorstensen K.
CS 13.4 Compartmental analysis of plasma n-3 fatty acids in male and female smokers and in male recovering alcoholics. Pawlosky R.
CS 13.5 Depletion of polyunsaturated fatty synthesis during diabetes and hypertension.
Narce M.
Chairs:Reto Muggli & Michel Lucas
CS 14.1 Relationship of maternal omega-3 fatty acid status in pregnancy and postnatal depression to behavioural problems in later childhood.
Forsyth S.
CS 14.2 Fish consumption, nutrition and developmental outcomes: the Seychelles Child Development Nutrition Study (SCDNS).
Strain J.
CS 14.3 Maternal cigarettte smoke during pregnancy markedly affects foetal growth and the n-3 lc pufa status in the newborn.
Galli C.
CS 14.4 Longitudinal assessment of erythrocyte fatty acid composition throughout pregnancy and post partum.
Meyer B.
CS 14.5 Relationship between docosahexaenoic acid in red blood cells of Icelandic pregnant women and outcome of pregnancy.
Magnusardottir A.
CS 14.6 Maternal trans status, and neonatal birth weight in the ABCD cohort.
Van Eijsden M.
Chairs:Paul Else & Ingeborg Brouwer
CS 15.1 Heart omega-3 changes within range of intakes associated with human cardiovascular risk reduction correlate with erythrocyte omega-3 index and are not influenced by omega-6 intake in the rat.
McLennan P.
CS 15.2 The effect of fish oil supplementation on myocardial fatty acids in humans.
Cleland L.
CS 15.3 Mercury exposure does not inhibit docosahexaenoic acid concentrations in rat heart phospholipids. Craig-Schmidt M.
CS 15.4 The fatty acid composition of atria and ventricle from healthy donor and explanted (failing) human heart.
Theiss M.
CS 15.5 Oral administration of eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions through lipid-lowering- independent mechanism in apo E-deficient mice.
Matsumoto M.
CS 15.6 N-3 fatty acids from omacor enter advanced atherosclerotic plaques and are associated with decreased inflammation and decreased inflammatory gene expression.
Calder P.
Chairs:Klaus Gawrisch & Lisa Smithers
CS 16.1 Improvement of retinal function of young dogs exposed to dietary long chain n-3 polyunsaturated fatty acids during fetal development and suckling.
Waldron M.
CS 16.2 Withdrawn
CS 16.3 Multiple factors attenuate retinal protein activity in omega-3 deficiency.
Weymouth A.
CS 16.4 Evidence for specific interactions of docosahexaenoic acid with sites on theGPCR rhodopsin – an NMR study. Gawrisch K.
CS 16.5 Effects of 32 and 34 carbon polyunsaturated acyl chains on membrane physical properties, receptor activation and G protein-coupled signal transduction.
Mitchell D.
|
Archive